Actively Recruiting
New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
Led by University Hospital, Grenoble · Updated on 2024-12-17
15
Participants Needed
1
Research Sites
43 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying chronic pelvic pain in transgender people who are using testosterone therapy. This observational, qualitative study aims to describe the characteristics of this pelvic pain, how it affects quality of life, and to understand factors that help or hinder consulting healthcare professionals. The study is led by the University Hospital in Grenoble and focuses on transmasculine individuals experiencing new or changed pelvic pain since starting testosterone. Participants in this study will be transmasculine individuals using gender-affirming hormonal therapy who have had pelvic pain for at least six months that appeared or changed after starting testosterone therapy. The study involves a single semi-structured interview lasting about 1.5 hours. During this interview, participants will discuss their pelvic pain and its impact on their lives, and pelvic pain intensity will be assessed at the start. Participants will be recruited through community groups and mailings and will complete one interview. Researchers will analyze the interview data qualitatively to better understand the pain experiences and barriers to care. The main outcome measured is the detailed description of pelvic pain and its effect on quality of life. The study is planned to run until December 2025.
CONDITIONS
Brief Title
New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Being a trans masculine individual
- Taking a gender affirming hormonal therapy (GAHT)
- Living close to Grenoble
- Having pelvic pain that appeared or was modified after taking GAHT
You will not qualify if you...
- Subject under guardianship or deprived of liberty
- Refusal of voice recording
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 1.5 hours during the interview
Participants undergo a semi-structured interview to describe their pelvic pain and its impact on quality of life.
1 interview visit (in-person or remote)
Trial Site Locations
Total: 1 location
1
UGA
Saint-Martin-d'Hères, France, 38100
Actively Recruiting
Research Team
S
SaraEve Graham Longsworth, MSc
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here